CVR 38238213Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)København ØFounded 28 Nov 2016
Employees
6
CVR registry, Aug 2026
-7 (-53.8%) over 12 months
Gross profit
-6.1M
DKK, annual report 2025
Result
-12.7M
DKK, annual report 2025
Equity
-9.6M
DKK, annual report 2025
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Perfusion Tech ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexRenew Pharmaceuticals Limited100% of capital and votes, since 22 Sep 2023
Declan Cassellssince 29 Sep 2025
Equity was negative at 31 Dec 2025: -9.6M DKK. Dandex estimate, computed 1 Nov 2026.
100% of capital and votessince 22 Sep 2023
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 2641536510% to under 15% of capital and votes28 Nov 2016 to 13 Dec 2020
CVR 3143138715% to under 20% of capital and votes28 Nov 2016 to 28 Feb 2017
CVR 340420125% to under 10% of capital and votes28 Nov 2016 to 22 Sep 2023
CVR 3524449210% to under 15% of capital and votes28 Nov 2016 to 13 Dec 2020
CVR 3819118710% to under 15% of capital and votes28 Nov 2016 to 4 Jun 2025
CVR 3819145410% to under 15% of capital and votes28 Nov 2016 to 4 Jun 2025
CVR 419538455% to under 10% of capital and votes21 Mar 2022 to 4 Jun 2025
CVR 419536165% to under 10% of capital and votes21 Mar 2022 to 4 Jun 2025
CVR records founders at incorporation. It does not record whether they are alive or still involved.
22 Sep 2023 to 1 Nov 2026.
28 Nov 2016 to 1 Nov 2026.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | -1,067 | -4,201 | -5,414 | -9,022 | -6,143 |
| Operating profit | -2,413 | -7,563 | -10,706 | -16,402 | -14,435 |
| Result for the year | -2,118 | -6,556 | -9,545 | -14,470 | -12,725 |
| Equity | -3,932 | 1,170 | 2,873 | 2,114 | -9,641 |
| Total assets | 1,264 | 4,888 | 8,832 | 5,585 | 4,587 |
| Employees (average) | 4 | 7 | 8 | 11 | 11 |
| Credit metrics (Dandex calculations) | |||||
| EBITDA | Not reportednote 1 | Not reportednote 1 | Not reportednote 1 | -16,395 | -14,418 |
| Employee growth (vækst i antal ansatte) | 33.3% | 75% | 14.3% | 37.5% | 0% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -403 | -3,435note 2 | -5,522 | -1,720 | -1,523 |
| Capex (investeringer i anlægsaktiver) | Not reportednote 3 | Not reportednote 3 | Not reportednote 3 | 85note 4 | 0note 5 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | -403 | -3,435note 2 | -5,522 | -1,720 | 11,805 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 9 Jun 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 24 Jun 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 25 Mar 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 7 Jun 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 27 May 2022
1 registered in CVR.
P-number 1021987685Viborggade 70, 2100 København Ø
No other current company drawn.
